Synergism of a novel MCL-1 downregulator, acriflavine, with navitoclax (ABT-263) in triple-negative breast cancer, lung adenocarcinoma and glioblastoma multiforme

por Lee, Anbok, Jin, Hyeon-Ok, Haque, Md. Masudul, Kim, Hee Yeon, Jung, Hana, Park, Jin Hee, Kim, Ilhwan, Song, Joo Yeon, Yoon, Hye Kyoung, Kim, Hyoung Kyu, Han, Jin, Park, In-Chul, Kim, Kwang Seok, Park, Sae Gwang
Publicado 2021